The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome

The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome

Abstract Background Fibroblast growth factor 21 (FGF21) is closely associated with metabolic syndrome (MetS). An alteration of FGF21 is possibly affected by periodontitis. The present study aimed to investigate the levels of serum FGF21 in MetS patients with generalized periodontitis and its associa...

Full description

Bibliographic Details
Main Authors: Teerat Sawangpanyangkura, Panwadee Bandhaya, Pattanin Montreekachon, Anongwee Leewananthawet, Arintaya Phrommintikul, Nipon Chattipakorn, Siriporn C. Chattipakorn
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Oral Health
Subjects:
FGF21, periodontitis
Metabolic syndrome
Online Access:https://doi.org/10.1186/s12903-022-02533-3

Internet

https://doi.org/10.1186/s12903-022-02533-3

Similar Items